A systematic review and meta-analysis comparing everolimus and calcineurin inhibitors (CNIs) to mycophenolate and CNIs in kidney transplant patients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A systematic review and meta-analysis comparing everolimus and calcineurin inhibitors (CNIs) to mycophenolate and CNIs in kidney transplant patients

Published:2023-03-31 Issue:1 Volume:37 Page:41-48
ISSN:2671-8790
Container-title:Korean Journal of Transplantation
language:en
Short-container-title:Korean J Transplant

Author:

Vergara-Rejante Larraine¹^ORCID,Tanhui Kristel K.¹^ORCID,Alolod Maria Kristina L.¹^ORCID

Affiliation:

1. Section of Nephrology, Department of Medicine, St. Luke’s Medical Center, Quezon City, Philippines

Publisher

The Korean Society for Transplantation

Subject

Transplantation,Immunology

Link

http://pdf.medrang.co.kr/JKST/2023/037/kjt-37-1-41.pdf

Reference25 articles.

1. The safety of calcineurin inhibitors for kidney-transplant patients

2. Randomized trial of tacrolimus + mycophenolate mofetil or azathioprine versus cyclosporine + mycophenolate mofetil after cadaveric kidney transplantation: results at three years

3. SDZ RAD, A NEW RAPAMYCIN DERIVATIVE

4. Pilot Randomized Trial of Tacrolimus/Everolimus vs Tacrolimus/Enteric-Coated Mycophenolate Sodium in Adult, Primary Kidney Transplant Recipients at a Single Center

5. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP